8-KMaterial AgreementsFinancial EventsOther Events

Cigna Group 8-K Report, Material Agreement (Apr 28, 2023)

Filed April 28, 2023For Securities:CI

Summary

Cigna Group (CI) has filed an 8-K report detailing the entry into new credit facilities, replacing its existing ones. The company has secured a $4.0 billion five-year revolving credit agreement and a $1.0 billion 364-day revolving credit agreement. These new facilities offer a combined borrowing capacity of $5.0 billion and include an option to increase commitments by an additional $1.5 billion, potentially bringing the total to $6.5 billion. The primary purpose of these agreements is to ensure continued access to liquidity for general corporate purposes and to support strategic initiatives. Investors should note that these agreements replace all prior revolving credit facilities, indicating a restructuring of Cigna's debt management and liquidity strategy. The terms include customary covenants and a financial leverage ratio restriction, aiming to maintain financial discipline.

Key Highlights

  • 1Cigna Group entered into two new revolving credit facilities on April 27, 2023.
  • 2A $4.0 billion Five-Year Revolving Credit Agreement and a $1.0 billion 364-Day Revolving Credit Agreement have been established.
  • 3These new agreements replace all of the company's existing revolving credit facilities.
  • 4The total initial commitment under the new Credit Agreements is $5.0 billion.
  • 5There is an option to increase commitments by an aggregate of $1.5 billion across both facilities, potentially reaching a total of $6.5 billion.
  • 6The Credit Agreements include a financial covenant limiting the leverage ratio to a maximum of 0.60 to 1.00 (or 0.65 to 1.00 following a qualifying acquisition).
  • 7Interest rates on advances are tied to base rates or term benchmark rates, plus an applicable margin based on Cigna's senior unsecured credit ratings.

Frequently Asked Questions

These new credit agreements are significant as they replace all of Cigna's existing revolving credit facilities, consolidating and modernizing the company's access to liquidity. They provide a substantial borrowing capacity of $5.0 billion, with an option for further expansion, ensuring the company has ample financial flexibility for its operational needs and strategic objectives.

The company has established a $4.0 billion five-year revolving credit facility and a $1.0 billion 364-day revolving credit facility. Both agreements allow for revolving borrowings and include an option to increase commitments by up to $1.5 billion in total. Interest rates are variable and linked to benchmark rates plus an applicable margin based on Cigna's credit ratings. Customary covenants, including a leverage ratio limit, are also in place.

The new agreements contain a financial covenant that restricts Cigna's leverage ratio (total consolidated debt to total consolidated capitalization) to a maximum of 0.60 to 1.00. This ratio can be temporarily increased to 0.65 to 1.00 following a significant acquisition (over $1.0 billion in cash consideration). This covenant aims to ensure the company maintains a prudent level of debt relative to its capital structure.

The Credit Agreements contain standard provisions for events of default, such as bankruptcy, insolvency, change of control, and cross-acceleration with other debt agreements. If an event of default occurs, it could lead to the termination of commitments or acceleration of outstanding debt, impacting the company's liquidity and financial standing.